Efficacy of neuromodulation on the treatment of fibromyalgia: A network meta-analysis
Journal
General Hospital Psychiatry
Journal Volume
87
Journal Volume
87
Pages
103-123
Start Page
103
End Page
123
ISSN
0163-8343
Date Issued
2024-03-01
Author(s)
Abstract
Several types of neuromodulation have been investigated for the treatment of fibromyalgia, but they show varied efficacy on pain, functioning, comorbid depression and comorbid anxiety. Whether some types of neuromodulation or some factors are associated with a better response also awaits clarification. We conducted a systematic review and network meta-analysis of randomized controlled trials to evaluate the efficacy of neuromodulation in patients with fibromyalgia. We searched PubMed, EMBASE, the Cochrane Central Register of Controlled Trials and PsycINFO before March 2022. We employed a frequentist random-effects network meta-analysis. Forty trials involving 1541 participants were included. Compared with sham control interventions, several types of transcranial direct current stimulation (tDCS), transcranial random noise stimulation (tRNS), and high-frequency repetitive transcranial magnetic stimulation (rTMS) were associated with significant reduction of pain, depression, anxiety, and improvement in functioning. Many significantly effective treatment options involve stimulation of the primary motor cortex or dorsolateral prefrontal cortex. We concluded that several types of rTMS, tDCS and tRNS may have the potential to be applied for clinical purposes.
SDGs
Publisher
Elsevier Inc.
Type
review